Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 285 TWD 2.33%
Market Cap: 76.1B TWD

Wall Street
Price Targets

Price Targets Summary
Lotus Pharmaceutical Co Ltd

Wall Street analysts forecast Lotus Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Lotus Pharmaceutical Co Ltd is 473.28 TWD with a low forecast of 395.92 TWD and a high forecast of 630 TWD.

Lowest
Price Target
395.92 TWD
39% Upside
Average
Price Target
473.28 TWD
66% Upside
Highest
Price Target
630 TWD
121% Upside
Lotus Pharmaceutical Co Ltd Competitors:
Price Targets
COLL
Collegium Pharmaceutical Inc
0% Upside
512
Grand Pharmaceutical Group Ltd
54% Upside
PBH
Prestige Consumer Healthcare Inc
24% Upside
4569
Kyorin Holdings Inc
6% Downside
170900
Dong-A ST Co Ltd
26% Upside
128940
Hanmi Pharm Co Ltd
9% Upside
MARKSANS
Marksans Pharma Ltd
34% Upside
1J5
Hyphens Pharma International Ltd
26% Upside

Revenue
Forecast

Revenue Estimate
Lotus Pharmaceutical Co Ltd

For the last 13 years the compound annual growth rate for Lotus Pharmaceutical Co Ltd's revenue is 31%. The projected CAGR for the next 3 years is 28%.

31%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Lotus Pharmaceutical Co Ltd

The compound annual growth rate of Lotus Pharmaceutical Co Ltd's operating income for the next 3 years is 26%.

N/A
Past Growth
26%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Lotus Pharmaceutical Co Ltd

The compound annual growth rate of Lotus Pharmaceutical Co Ltd's net income for the next 3 years is 22%.

N/A
Past Growth
22%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Lotus Pharmaceutical Co Ltd's stock price target?
Price Target
473.28 TWD

According to Wall Street analysts, the average 1-year price target for Lotus Pharmaceutical Co Ltd is 473.28 TWD with a low forecast of 395.92 TWD and a high forecast of 630 TWD.

What is Lotus Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
28%

For the last 13 years the compound annual growth rate for Lotus Pharmaceutical Co Ltd's revenue is 31%. The projected CAGR for the next 3 years is 28%.

What is Lotus Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
26%

The compound annual growth rate of Lotus Pharmaceutical Co Ltd's operating income for the next 3 years is 26%.

What is Lotus Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
22%

The compound annual growth rate of Lotus Pharmaceutical Co Ltd's net income for the next 3 years is 22%.

Back to Top